Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J. 2020;84:831–65.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary—a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145:e4-17.
Valgimigli M, Cao D, Angiolillo DJ, Bangalore S, Bhatt DL, Ge J, et al. Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI. J Am Coll Cardiol. 2021;78:2060–72.
Article CAS PubMed Google Scholar
Giacoppo D, Matsuda Y, Fovino LN, D’Amico G, Gargiulo G, Byrne RA, et al. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials. Eur Heart J. 2021;42:308–19.
Article CAS PubMed Google Scholar
Han J-K, Hwang D, Yang S, Park S-H, Kang J, Yang H-M, et al. Comparison of 3- to 6-month versus 12-month dual antiplatelet therapy after coronary intervention using the contemporary drug-eluting stents with ultrathin struts: the HOST-IDEA randomized clinical trial. Circulation. 2023;147:1358–68.
Article CAS PubMed Google Scholar
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, et al. An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial. Circulation. 2024;149:585–600.
Article CAS PubMed Google Scholar
Kogame N, Guimarães PO, Modolo R, De Martino F, Tinoco J, Ribeiro EE, et al. Aspirin-free prasugrel monotherapy following coronary artery stenting in patients with stable CAD: the ASET pilot study. JACC Cardiovasc Interv. 2020;13:2251–62.
Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, et al. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (prevention of late stent thrombosis by an interdisciplinary global European effort). Circulation. 2017;136:1007–21.
Article PubMed PubMed Central Google Scholar
Matsumoto T, Kitahara H, Yamazaki T, Hiraga T, Yamashita D, Sato T, et al. Very short-term tissue coverage of the CD34 antibody-covered sirolimus-eluting stent: an optical coherence tomography study. Cardiovasc Interv Ther. 2023;38:381–7.
Article CAS PubMed Google Scholar
Saito S, Krucoff MW, Nakamura S, Mehran R, Maehara A, Al-Khalidi HR, et al. Japan-United States of America harmonized assessment by randomized multicentre study of OrbusNEich’s Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome. Eur Heart J. 2018;39:2460–8.
Article CAS PubMed PubMed Central Google Scholar
Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, et al. Coronary in-stent restenosis: JACC state-of-the-art review. J Am Coll Cardiol. 2022;80:348–72.
Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, et al. Clinical expert consensus document on intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics (2021). Cardiovasc Interv Ther. 2022;37:40–51.
Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. Cardiovasc Interv Ther. 2022;37:1–34.
Article PubMed PubMed Central Google Scholar
Fujii K, Kubo T, Otake H, Nakazawa G, Sonoda S, Hibi K, et al. Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022. Cardiovasc Interv Ther. 2022;37:248–54.
Suzuki N, Asano T, Nakazawa G, Aoki J, Tanabe K, Hibi K, et al. Clinical expert consensus document on quantitative coronary angiography from the Japanese association of cardiovascular intervention and therapeutics. Cardiovasc Interv Ther. 2020;35:105–16.
Article CAS PubMed PubMed Central Google Scholar
Lee SW, Lam SC, Tam FC, Chan KK, Shea CP, Kong SL, et al. Evaluation of early healing profile and neointimal transformation over 24 months using longitudinal sequential optical coherence tomography assessments and 3-year clinical results of the new dual-therapy endothelial progenitor cell capturing sirolimus-eluting combo stent: the EGO-combo study. Circ Cardiovasc Interv. 2016;9: e003469.
Article CAS PubMed Google Scholar
Saito Y, Kobayashi Y. Contemporary coronary drug-eluting and coated stents: a mini-review. Cardiovasc Interv Ther. 2021;36:20–2.
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Article CAS PubMed Google Scholar
Nakazawa G, Granada JF, Alviar CL, Tellez A, Kaluza GL, Guilhermier MY, et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv. 2010;3:68–75.
Larsen K, Cheng C, Tempel D, Parker S, Yazdani S, den Dekker WK, et al. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur Heart J. 2012;33:120–8.
Article CAS PubMed Google Scholar
Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.
Jaguszewski M, Aloysius R, Wang W, Bezerra HG, Hill J, De Winter RJ, et al. The REMEDEE-OCT study: an evaluation of the bioengineered COMBO dual-therapy CD34 antibody-covered sirolimus-eluting coronary stent compared with a cobalt-chromium everolimus-eluting stent in patients with acute coronary syndromes: insights from optical coherence tomography imaging analysis. JACC Cardiovasc Interv. 2017;10:489–99.
Jakobsen L, Christiansen EH, Freeman P, Kahlert J, Veien K, Maeng M, et al. Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting combo stent with the sirolimus-eluting orsiro stent in patients treated with percutaneous coronary intervention: the SORT OUT X trial. Circulation. 2021;143:2155–65.
Article CAS PubMed Google Scholar
Ndunda P, Vindhyal MR, Muutu T, Fanari Z. Clinical outcomes of the dual-therapy CD34 antibody-covered sirolimus-eluting stent versus standard drug-eluting coronary stents: a meta-analysis. Cardiovasc Revasc Med. 2020;21:213–21.
Otaegui Irurueta I, González Sucarrats S, Barrón Molina JL, de Prado AP, Massotti M, Carmona Ramírez MÁ, et al. Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial: an intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent. Int J Cardiol. 2022;360:13–20.
Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–78.
Article CAS PubMed Google Scholar
Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118:1138–45.
Palmerini T, Bacchi Reggiani L, Della Riva D, Romanello M, Feres F, Abizaid A, et al. Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting. J Am Coll Cardiol. 2017;69:2011–22.
Holmes DR Jr, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, et al. Stent thrombosis. J Am Coll Cardiol. 2010;56:1357–65.
Araki M, Park S-J, Dauerman HL, Uemura S, Kim J-S, Di Mario C, et al. Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol. 2022;19:684–703.
Comments (0)